Sector exposure

Pharma

10 funds with Pharma exposure · weighted average allocation 43.2% · 755th largest sector ranked across tracked funds

Funds
10
Avg weight
43.2%
Sector rank
#755 of 1360
AI Analysis · Pharma Powered by Claude · live
Generating analysis…

AI outlook will appear here once data is loaded.

Momentum
Valuation
Fund sentiment
community voting · coming soon
Build a screen from this →

Top Pharma-exposed funds

Sorted by sector weight · 10 funds total
Fund
Manager
Sector weight
1Y return
CE
Candriam Equities L Oncology
LU1864481541
Candriam
60.2%
+21.8%
WH
World Healthscience Fund
LU0122380701
BlackRock
48.8%
+3.9%
BS
Bellevue Sustainable Healthcare
LU1819585370
Bellevue Asset Management
46.3%
+1.5%
CE
Candriam Equities L Biotechnology
LU0108459552
Candriam
44.4%
+57.6%
IH
International Health Care Portfolio
LU0037065322
AllianceBernstein
43.9%
+4%
GH
Global Healthcare Fund
LU0432979374
J.P. Morgan Asset Management
40.7%
+8.1%
TS
Tareno Sustainable Healthcare Fund
LU0996778642
Tareno
38.5%
-0.2%
BE
Bellevue Emerging Markets Healthcare
LU1585228296
Bellevue Asset Management
37.4%
+11.1%
BA
Bellevue Asia Pacific Healthcare
LU1587984680
Bellevue Asset Management
36.7%
+4.9%
XM
Xtrackers MSCI USA Health Care UCITS ETF
IE000RNHIKK1
DWS
35.4%
+3%
Top Pharma Holdings Across Funds
JOHNSON & JOHNSON
Unknown
9.95%
in 4 funds
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Unknown
9.61%
in 1 funds
HOYA CORPORATION
Unknown
9.15%
in 1 funds
ELI LILLY AND COMPANY
Unknown
8.77%
in 6 funds
LILLY (ELI) & CO
Unknown
7.3%
in 1 funds
CHUGAI PHARMACEUTICAL CO
Unknown
6.84%
in 1 funds
CSL LIMITED
Unknown
6.63%
in 1 funds
INNOVENT BIOLOGICS INC
Unknown
6.52%
in 1 funds
Conviction Score vs MSCI Benchmark
Fund weight vs MSCI World benchmark (0%)
Candriam Equities L ..
+60.2%
World Healthscience ..
+48.8%
Bellevue Sustainable..
+46.3%
Candriam Equities L ..
+44.4%
International Health..
+43.9%
Global Healthcare Fund
+40.7%
Tareno Sustainable H..
+38.5%
Bellevue Emerging Ma..
+37.4%
Bellevue Asia Pacifi..
+36.7%
Xtrackers MSCI USA H..
+35.4%
Performance Chart
Top 10-fund composite (rebased to 100, equal-weighted) Pharma ETF (benchmark) Real fund NAV data 2025-05-14 → 2026-04-30
Pharma Sector News
Loading news...